NCT05279014 is a NA clinical trial of Meal timing in Cardiovascular Diseases, sponsored by University of Bath.

Who is sponsoring NCT05279014?

NCT05279014 is sponsored by University of Bath.

What drugs are being tested in NCT05279014?

Interventions in NCT05279014: Meal timing.

What condition does NCT05279014 study?

NCT05279014 studies Cardiovascular Diseases.

Is NCT05279014 still recruiting?

NCT05279014 is currently completed. Last updated 27 March 2025.

Last reviewed 2025-03-27 · How we verify

NCT05279014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fasted Exercise and LDL-C

Completed NA Last updated 27 March 2025

What this trial tests

NA trial testing Meal timing in Cardiovascular Diseases in 29 participants. Completed in 30 August 2024.

Timeline

30 March 2022

Primary endpoint
13 August 2024

30 August 2024

Quick facts

Lead sponsor	University of Bath
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	29
Start date	30 March 2022
Primary completion	13 August 2024
Estimated completion	30 August 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Meal timing

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

University of Bath

Who can join

Adults 25 to 60, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular disease (CVD) is the leading cause of death in the UK and worldwide with low density lipoprotein cholesterol (LDL-C) being one of the most important modifiable risk factors. Physical activity is inexpensive and research shows that it consistently improves high density lipoprotein and triglyceride concentrations. However, fails to improve LDL-C concentrations. Preliminary research suggests fasted exercise could potentially improve LDL-C concentrations. The majority of research in these areas have also mostly been done in males with the results generalised to females. As it is known that lipid metabolism and CVD risk is different between sexes it is possible that the response to fasted exercise may also be different between sexes. This aim of this study is to assess the effect of physical activity performed before or after a meal on plasma LDL-C concentrations in men and women and explore sex differences. The study will also assess the effect of fasted exercise on other CVD risk factors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of exercise in a fasted state on plasma low-density lipoprotein cholesterol concentrations in males and females.
Bradshaw L, Koumanov F, Berry S, Betts JA, et al · · 2023 · cited 1× · PMID 36809567 · DOI 10.1113/ep091005

Verify or expand the search:

Other trials of Meal timing

Trials testing the same drug.

NCT06887543 — The Impact of Time Restricted Eating on Type 2 Diabetes · NA · terminated
NCT03490825 — Aging Program Project Grant 6 · NA · completed

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other University of Bath trials

Trials by the same sponsor.

NCT07360249 — Glucose-fructose Ratio Pilot · NA · recruiting
NCT06967077 — Exploring the Feasibility and Acceptability of Virtual Reality Exercise for Pain Management, Fear of Movement, Mobility, · NA · not yet recruiting
NCT07472244 — Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation? · NA · recruiting
NCT07099911 — Neuromuscular Electrical Stimulation and Glucose Control in Spinal Cord Injury · NA · recruiting
NCT07027553 — Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05279014 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bath
Last refreshed: 27 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05279014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing